Related Experiment Video
Updated: May 10, 2025

An Immunohistopathologic Study to Profile the Folate Receptor Beta Macrophage and Vascular Immune Microenvironment in Giant Cell Arteritis
Published on: February 8, 2019
Investigating the Challenges in Diagnosis and Management of Giant Cell Tumors in the Distal Phalanx: A Case Report
Jason S DeFrancisis1,2, Oren D Rosenthal3, Theodore C Whitford4
1Orthopedic Surgery, Lake Erie College of Osteopathic Medicine, Bradenton, USA.
Abstract:
Giant cell tumors (GCTs) of bone are locally aggressive neoplasms that typically occur in the distal femur or proximal tibia. Infrequently, they may develop in the bones of the hand, including the distal phalanx. This case highlights the importance of a thorough and systematic diagnostic workup of GCTs presenting in rare and challenging locations such as the distal phalanx. A 53-year-old male presented to the clinic with a several-month history of left middle fingertip enlargement, pain, and limited mobility. Plain film X-ray and magnetic resonance imaging revealed a lesion in the left middle distal phalanx. The patient underwent curettage with a working diagnosis of giant cell reparative granuloma with focal fracture callus. Eight months later the mass recurred and amputation of the distal phalanx tip was performed. The histopathological evaluation confirmed a diagnosis of a giant cell tumor of bone. The postoperative course was unremarkable. No further treatment was required. In rare and difficult-to-diagnose tumors clinicians should consult with experienced pathologists to improve diagnostic accuracy. This approach is essential for optimizing patient outcomes, preventing treatment delays, and reducing the risk of adverse events.
More Related Videos
07:50Utilization of Ultrasound Guided Tissue-directed Cellular Implantation for the Establishment of Biologically Relevant Metastatic Tumor Xenografts
Published on: May 25, 2018
06:53Modeling Primary Bone Tumors and Bone Metastasis with Solid Tumor Graft Implantation into Bone
Published on: September 9, 2020